These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 31699275)

  • 1. Coronary Functional Abnormalities in Patients With Angina and Nonobstructive Coronary Artery Disease.
    Suda A; Takahashi J; Hao K; Kikuchi Y; Shindo T; Ikeda S; Sato K; Sugisawa J; Matsumoto Y; Miyata S; Sakata Y; Shimokawa H
    J Am Coll Cardiol; 2019 Nov; 74(19):2350-2360. PubMed ID: 31699275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease.
    Ohba K; Sugiyama S; Sumida H; Nozaki T; Matsubara J; Matsuzawa Y; Konishi M; Akiyama E; Kurokawa H; Maeda H; Sugamura K; Nagayoshi Y; Morihisa K; Sakamoto K; Tsujita K; Yamamoto E; Yamamuro M; Kojima S; Kaikita K; Tayama S; Hokimoto S; Matsui K; Sakamoto T; Ogawa H
    J Am Heart Assoc; 2012 Oct; 1(5):e002485. PubMed ID: 23316292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impacts of Rho-kinase activity in circulating leucocytes in patients with vasospastic angina.
    Nihei T; Takahashi J; Hao K; Kikuchi Y; Odaka Y; Tsuburaya R; Nishimiya K; Matsumoto Y; Ito K; Miyata S; Sakata Y; Shimokawa H
    Eur Heart J; 2018 Mar; 39(11):952-959. PubMed ID: 29165549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistive reserve ratio and microvascular resistance reserve in patients with coronary vasospastic angina.
    Saito Y; Nishi T; Kato K; Kitahara H; Kobayashi Y
    Heart Vessels; 2022 Sep; 37(9):1489-1495. PubMed ID: 35301553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Yield and Clinical Utility of Coronary Angiography Versus Coronary Function Testing in Women With Angina and Nonobstructive Coronary Arteries.
    Cigarroa N; Latif N; Maayah M; Khokhar A; Kunnirickal S; Schwann A; Maciejewski KR; Odanovic N; Mazure CM; Spatz E; Pfau S; Lansky A; Shah SM
    J Am Heart Assoc; 2024 Oct; 13(19):e035852. PubMed ID: 39291500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries.
    Odaka Y; Takahashi J; Tsuburaya R; Nishimiya K; Hao K; Matsumoto Y; Ito K; Sakata Y; Miyata S; Manita D; Hirowatari Y; Shimokawa H
    Eur Heart J; 2017 Feb; 38(7):489-496. PubMed ID: 27694191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Follow-Up in Patients With Stable Angina and Unobstructed Coronary Arteries Undergoing Intracoronary Acetylcholine Testing.
    Seitz A; Gardezy J; Pirozzolo G; Probst S; Athanasiadis A; Hill S; Mahrholdt H; Bekeredjian R; Sechtem U; Ong P
    JACC Cardiovasc Interv; 2020 Aug; 13(16):1865-1876. PubMed ID: 32739303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm.
    Mohri M; Shimokawa H; Hirakawa Y; Masumoto A; Takeshita A
    J Am Coll Cardiol; 2003 Jan; 41(1):15-9. PubMed ID: 12570938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute Coronary Blood Flow Measured by Continuous Thermodilution in Patients With Ischemia and Nonobstructive Disease.
    Konst RE; Elias-Smale SE; Pellegrini D; Hartzema-Meijer M; van Uden BJC; Jansen TPJ; Vart P; Gehlmann H; Maas AHEM; van Royen N; Damman P
    J Am Coll Cardiol; 2021 Feb; 77(6):728-741. PubMed ID: 33573743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased resting coronary flow and impaired endothelial function in patients with vasospastic angina.
    Saito Y; Kitahara H; Nishi T; Fujimoto Y; Kobayashi Y
    Coron Artery Dis; 2019 Jun; 30(4):291-296. PubMed ID: 30702507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary Adventitial and Perivascular Adipose Tissue Inflammation in Patients With Vasospastic Angina.
    Ohyama K; Matsumoto Y; Takanami K; Ota H; Nishimiya K; Sugisawa J; Tsuchiya S; Amamizu H; Uzuka H; Suda A; Shindo T; Kikuchi Y; Hao K; Tsuburaya R; Takahashi J; Miyata S; Sakata Y; Takase K; Shimokawa H
    J Am Coll Cardiol; 2018 Jan; 71(4):414-425. PubMed ID: 29389358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodilutional Confirmation of Coronary Microvascular Dysfunction in Patients With Recurrent Angina After Successful Percutaneous Coronary Intervention.
    Li Y; Yang D; Lu L; Wu D; Yao J; Hu X; Long M; Luo C; Du Z
    Can J Cardiol; 2015 Aug; 31(8):989-97. PubMed ID: 26088108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina.
    Masumoto A; Mohri M; Shimokawa H; Urakami L; Usui M; Takeshita A
    Circulation; 2002 Apr; 105(13):1545-7. PubMed ID: 11927519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina.
    Fukumoto Y; Mohri M; Inokuchi K; Ito A; Hirakawa Y; Masumoto A; Hirooka Y; Takeshita A; Shimokawa H
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):117-21. PubMed ID: 17414222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angina pectoris caused by coronary microvascular spasm.
    Mohri M; Koyanagi M; Egashira K; Tagawa H; Ichiki T; Shimokawa H; Takeshita A
    Lancet; 1998 Apr; 351(9110):1165-9. PubMed ID: 9643687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-wire pressure and flow velocity measurement for quantifying microvascular dysfunction in patients with coronary vasospastic angina.
    Yamanaga K; Tsujita K; Komura N; Kaikita K; Sakamoto K; Miyazaki T; Saito M; Ishii M; Tabata N; Akasaka T; Sato K; Horio E; Arima Y; Kojima S; Tayama S; Nakamura S; Hokimoto S; Ogawa H
    Am J Physiol Heart Circ Physiol; 2015 Mar; 308(5):H478-84. PubMed ID: 25527779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm.
    Konst RE; Damman P; Pellegrini D; Hartzema-Meijer MJ; van Uden BJC; Jansen TPJ; Brandsma J; Vart P; Gehlmann H; Maas AHEM; van Royen N; Elias-Smale SE
    Int J Cardiol; 2021 Jun; 333():14-20. PubMed ID: 33711394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries).
    Ong P; Athanasiadis A; Borgulya G; Mahrholdt H; Kaski JC; Sechtem U
    J Am Coll Cardiol; 2012 Feb; 59(7):655-62. PubMed ID: 22322081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivessel Coronary Function Testing Increases Diagnostic Yield in Patients With Angina and Nonobstructive Coronary Arteries.
    Rehan R; Wong CCY; Weaver J; Chan W; Tremmel JA; Fearon WF; Ng MKC; Yong ASC
    JACC Cardiovasc Interv; 2024 May; 17(9):1091-1102. PubMed ID: 38749588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina.
    Otsuka T; Ibuki C; Suzuki T; Ishii K; Yoshida H; Kodani E; Kusama Y; Atarashi H; Kishida H; Takano T; Mizuno K
    Coron Artery Dis; 2008 Mar; 19(2):105-10. PubMed ID: 18300747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.